UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 276

Sortiert nach

Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial

The Lancet (British edition), 2018-10, Vol.392 (10157), p.1530-1540

2018

Volltextzugriff (PDF)

Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials)

The American journal of cardiology, 2000-08, Vol.86 (3), p.336-341

2000

Volltextzugriff (PDF)

CASE 11—2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?

Journal of cardiothoracic and vascular anesthesia, 2016-12, Vol.30 (6), p.1698-1708

2016

Volltextzugriff (PDF)

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

The American journal of cardiology, 1999-08, Vol.84 (4), p.391-395

1999

Volltextzugriff (PDF)

Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management

Catheterization and cardiovascular interventions, 2001-03, Vol.52 (3), p.279-286

2001

Volltextzugriff (PDF)

Thrombosis and drug-eluting stents: a critical appraisal

Reviews in cardiovascular medicine, 2004, Vol.5 (1), p.9-15

2004

Volltextzugriff (PDF)

Dalteparin in combination with abciximab during percutaneous coronary intervention

The American heart journal, 2001-03, Vol.141 (3), p.348-352

2001

Volltextzugriff (PDF)

IIb’s are not IIb’s

The American journal of cardiology, 2000-04, Vol.85 (8), p.23-31

2000

Volltextzugriff (PDF)

Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab

The American heart journal, 2001-11, Vol.142 (5), p.790-798

2001

Volltextzugriff (PDF)

Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa Receptor Blockade with oral xemilofiban: Results of a multicenter, placebo-controlled, randomized Trial

Circulation (New York, N.Y.), 1998-09, Vol.98 (13), p.1268-1278

1998

Volltextzugriff (PDF)

Cocaine-Induced Coronary-Artery Dissection

The New England journal of medicine, 1994-02, Vol.330 (7), p.510-511

1994

Volltextzugriff (PDF)

Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment

Circulation (New York, N.Y.), 1997-08, Vol.96 (4), p.1117-1121

1997

Volltextzugriff (PDF)

Abciximab provides cost-effective survival advantage in high-volume interventional practice

The American heart journal, 2000-10, Vol.140 (4), p.603-610

2000

Volltextzugriff (PDF)

Successful long-term therapy following saphenous vein-covered stent deployment for atherosclerotic coronary aneurysm

Catheterization and cardiovascular interventions, 2002-01, Vol.55 (1), p.100-104

2002

Volltextzugriff (PDF)

Accelerating the return to work (RTW) chances of coronary heart disease (CHD) patients: part 1 - development and validation of a training programme

Disability and rehabilitation, 2000-01, Vol.22 (13-14), p.604-620

Mital, Donald E. Shrey, Majorkumar Govindaraju, Thomas M. Broderick, Kathy Colon-Brown, Byron W. Gustin, Anil

2000

Volltextzugriff (PDF)

Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary intervention

The American heart journal, 2003-02, Vol.145 (2), p.e6-e6

2003

Volltextzugriff (PDF)

Partial Reversal of Heparin Anticoagulation by Intravenous Protamine in Abciximab-Treated Patients Undergoing Percutaneous Intervention

The American journal of cardiology, 1997-09, Vol.80 (5), p.633-634

1997

Volltextzugriff (PDF)

Quantification of abciximab-induced platelet inhibition is assay dependent: A comparative study in patients undergoing percutaneous coronary intervention

The American heart journal, 2003-02, Vol.145 (2), p.M1-M6

2003

Volltextzugriff (PDF)

Combination antiplatelet therapy following brachytherapy with restenting: it ain't over 'til the fat lady sings

The Journal of invasive cardiology, 2002-03, Vol.14 (3), p.115

2002

Volltextzugriff (PDF)

Intragraft verapamil: an ounce of prevention is worth a pound of cure

The Journal of invasive cardiology, 2002-06, Vol.14 (6), p.303-304

2002

Volltextzugriff (PDF)

Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?

Journal of cardiothoracic and vascular anesthesia, 2016

2016

Volltextzugriff (PDF)

High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonists

Journal of thrombosis and thrombolysis, 2000-02, Vol.9 (2), p.149-155

2000

Volltextzugriff (PDF)

Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion

The American journal of cardiology, 1996, Vol.78 (10), p.1161-1163

1996

Volltextzugriff (PDF)

Therapeutic adjuncts for immediate transfer to the catheterization laboratory in patients with acute coronary syndromes

The American journal of cardiology, 2000-12, Vol.86 (12), p.10-17

2000

Volltextzugriff (PDF)

Regional Wall Motion Index for Infarct and Noninfarct Regions after Reperfusion in Acute Myocardial Infarction: Comparison With Global Wall Motion Index

Journal of the American Society of Echocardiography, 1989-11, Vol.2 (6), p.398-407

1989

Volltextzugriff (PDF)

1 – 25 von 276

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(257)
Mit Volltextzugriff
(247)

Publikationsform

Sprache

Englisch
(276)
Japanisch
(62)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(197)
Life Sciences & Biomedicine
(156)
Humans
(145)
Male
(93)
Female
(91)
Biological And Medical Sciences
(81)
Medical Sciences
(76)
Middle Aged
(74)
Cardiovascular System & Cardiology
(68)
Aged
(55)
Neurosciences & Neurology
(54)
Clinical Neurology
(52)
Adult
(47)
Treatment Outcome
(47)
Peripheral Vascular Disease
(45)
Neurology
(43)
Vascular Diseases And Vascular Malformations Of The Nervous System
(36)
Physical Sciences
(32)
Astronomy & Astrophysics
(30)
Cardiac & Cardiovascular Systems
(30)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial

Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials)

CASE 11—2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management

Thrombosis and drug-eluting stents: a critical appraisal

Dalteparin in combination with abciximab during percutaneous coronary intervention

IIb’s are not IIb’s

Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab

Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa Receptor Blockade with oral xemilofiban: Results of a multicenter, placebo-controlled, randomized Trial

Cocaine-Induced Coronary-Artery Dissection

Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment

Abciximab provides cost-effective survival advantage in high-volume interventional practice

Successful long-term therapy following saphenous vein-covered stent deployment for atherosclerotic coronary aneurysm

Accelerating the return to work (RTW) chances of coronary heart disease (CHD) patients: part 1 - development and validation of a training programme

Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary intervention

Partial Reversal of Heparin Anticoagulation by Intravenous Protamine in Abciximab-Treated Patients Undergoing Percutaneous Intervention

Quantification of abciximab-induced platelet inhibition is assay dependent: A comparative study in patients undergoing percutaneous coronary intervention

Combination antiplatelet therapy following brachytherapy with restenting: it ain't over 'til the fat lady sings

Intragraft verapamil: an ounce of prevention is worth a pound of cure

Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?

High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonists

Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion

Therapeutic adjuncts for immediate transfer to the catheterization laboratory in patients with acute coronary syndromes

Regional Wall Motion Index for Infarct and Noninfarct Regions after Reperfusion in Acute Myocardial Infarction: Comparison With Global Wall Motion Index

Suchergebnisse filtern